Publications by authors named "Angela Quinto"

Claim this Profile
A
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy.
Grazia Gargano, Susanna Anita Pappagallo, Angela Maria Quinto, Bernardo Rossini, Doriana Gramegna

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Fortunato Morabito, Enrica Antonia Martino, Monica Galli, Massimo Offidani, Renato Zambello, Angela Maria Quinto

Eur J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Sofia Terlizzi, Giovanni Reddiconto, Angela Maria Quinto

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Paola Stefanoni, Silvia Mangiacavalli, Angela Maria Quinto

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of isatuximab-pomalidomide-dexamethasone elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.
Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Angela Maria Quinto

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.
Vanda Strafella, Immacolata Attolico, Paola Carluccio, Francesco Tarantini, Paola Curci, Angela Maria Quinto

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is whole body low dose CT still necessary in the era of F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients?
Nicola Maggialetti, Cristina Ferrari, Anna Giulia Nappi, Angela Quinto, Bernardo Rossini

Hell J Nucl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Giuseppe Mele, Nicola Di Renzo, Nicola Cascavilla, Angelo Michele Carella, Attilio Guarini, Angela Maria Quinto

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology.
Gian Maria Zaccaria, Vito Colella, Simona Colucci, Felice Clemente, Fabio Pavone, Angela Maria Quinto

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary, Bilateral and Diffuse Renal Non-Hodgkin's Lymphoma in a Young Woman Suffering from Turner Syndrome.
Bernardo Rossini, Tetiana Skrypets, Carla Minoia, Angela Maria Quinto, Gian Maria Zaccaria

J Pers Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper.
Alessandro Busca, Chiara Cattaneo, Elena De Carolis, Gianpaolo Nadali, Massimo Offidani, Angela Maria Quinto

Crit Rev Oncol Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.
Giuseppe Mele, Domenico Pastore, Nicola Di Renzo, Alberto Fragasso, Attilio Guarini, Angela Maria Quinto

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, Mario Tumbarello, Laura Angelici, Angela Maria Quinto

Ann Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Provision of Care for Long-term Survivors of Lymphoma.
Sabino Ciavarella, Carla Minoia, Angela Maria Quinto, Stefano Oliva, Santa Carbonara

Clin Lymphoma Myeloma Leuk· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis